Figure 1.
Cancer-associated fibroblasts are enriched in tumor of lung adenocarcinoma patients with OSA. The protein level of FAP (A and B) and α-SMA (A and C) in tumors from lung adenocarcinoma patients with OSA (n = 14) or without OSA (WO, n = 11). (D) The area percentage of cancer-associated fibroblast (α-SMA+) (indicated by red arrows) in tumors from lung adenocarcinoma patients with (OSA, n = 14) or without OSA (WO, n = 11).